Satraplatin is a Pt(IV) prodrug and the route to satraplatin is still in debate. In this article the authors propose a iodo-bridged intermediate and an improved synthesis to this intermediate. Really nice work and characterization methods.
http://www.sciencedirect.com/science/article/pii/S0020169314005477
atraplatin, also known as JM216, is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. Satraplatin
ReplyDelete